Harris Associates L P Adds $320M in ICON Public Limited Company ($ICLR)
Harris Associates significantly increased its investment in ICON Public Limited Company, adding 1.84 million shares.
Key Points
- Harris Associates increased its stake in ICON Public Limited Company by 73.3%, adding 1.84 million shares for a total of 4.35 million shares.
- ICON Public Limited Company has a market cap of $12.33 billion, a P/E ratio of 70.91, and traded near $160.96 on Friday.
- Analysts from RBC Capital upgraded the stock to 'buy' with a $185 target, while Citigroup maintained a 'hold' rating.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Harris Associates L P has significantly increased its stake in ICON Public Limited Company (NasdaqGS: ICLR). As of the latest 13F filing with the SEC, the fund added 1,841,151 shares, boosting its holdings by 73.3% to a total of 4,351,317 shares, valued at approximately $700.39 million.
Harris Associates L P vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
What Changed in Harris Associates's ICON Public Limited Company Position
Harris Associates increased its position in ICON Public Limited Company by 73.3%, according to the latest filing. The fund now holds 4,351,317 shares, up from 2,510,166 shares previously, adding 1,841,151 shares. The reported value of this stake is about $700.39 million.
Other Institutional Activity in ICON Public Limited Company
In addition to Harris Associates, several other institutional investors adjusted their positions in ICON Public Limited Company. Artisan Partners Limited Partnership grew its holdings by 1,404,968 shares, ending with 8,278,945 shares worth approximately $916.15 million. Wellington Management Group LLP increased its position by 1,562,287 shares to a total of 5,913,037 shares, valued at around $654.34 million. FMR LLC added 1,076,111 shares, bringing its total to 4,174,006 shares valued at roughly $461.90 million. Invesco Ltd. also increased its stake by 121,973 shares, now holding 3,878,869 shares worth about $429.24 million.
ICON Public Limited Company Stock Up 2.2%
Shares of ICON Public Limited Company traded near $160.96 on Friday. The company has a market capitalization of $12.33 billion and a P/E ratio of 70.91, with a forward P/E of 13.62. The stock's 52-week range is between $66.57 and $211.00. Its 50-day moving average is $127.80, while the 200-day moving average stands at $149.18. The company has a current ratio of 1.14 and a quick ratio of 1.09, with a debt-to-equity ratio of 37.72.
$ICLR stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
For its recent quarter, ICON Public Limited Company reported revenue of $8.27 billion, reflecting a growth of 1.6%. The company posted an EPS of $2.27, with a net margin of 2.1% and a return on equity of 1.8%. ICON is expected to report its next earnings on June 23, 2026.
Insider Buying and Selling at ICON Public Limited Company
Recent insider activity at ICON Public Limited Company included several transactions on May 14, 2026. Dr. John Climax bought and sold 5,005 shares, while Ronan Martin Murphy also executed similar transactions. Eugene Pacelli McCague bought and sold 3,255 shares. These transactions were not under Rule 10b5-1 plans.
Analysts Set New Price Targets
On June 25, 2026, several analysts updated their ratings and price targets for ICON Public Limited Company. RBC Capital upgraded the stock to a 'buy' with a $185 price target. Citigroup maintained a 'hold' rating and a $165 target, while BMO Capital and TD Cowen both maintained 'buy' ratings with targets of $187 and $197, respectively. The consensus among 16 analysts is a 'buy' rating, with an average target price of $175.31.
About ICON Public Limited Company
ICON Public Limited Company is a clinical research organization based in Dublin, Ireland. It provides outsourced development and commercialization services, specializing in clinical development from compound selection to Phase I-IV studies. With approximately 40,100 employees, ICON serves the pharmaceutical, biotechnology, and medical device industries globally. The company is led by CEO Mr. Barry Balfe and has a strategic alliance with Advarra, Inc. for clinical trial site network development.
Bottom Line
Harris Associates' substantial increase in its stake in ICON Public Limited Company highlights the firm's confidence in the company's prospects. Investors closely monitor these filings as they offer insights into institutional sentiment. Remember, 13F filings reflect past positions and may not indicate current holdings.
Get ICON Public Limited Company alerts
New 13F filings, insider trades, and analyst moves on $ICLR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.